Omkar Pharmachem Limited has announced that its board of directors will meet on Saturday, May 30, 2026, to consider the audited financial results for the quarter and financial year ended March 31, 2026. The meeting is scheduled to take place at 5:00 P.M. at the company's registered office.

Agenda for the Meeting

The primary agenda item for the board meeting is the consideration and approval of the audited financial results for the fourth quarter and the full financial year ending March 31, 2026. This disclosure is being made pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

In continuation of a previous intimation dated March 25, 2026, regarding the closure of the trading window, the company has informed the exchanges that the window will remain closed. The closure is in accordance with the company's Code of Conduct to Regulate, Monitor and Report Trading in Securities.

The trading window shall continue to remain closed until June 1, 2026, inclusive. This restriction applies to all designated persons of the company and their immediate relatives.

Omkar Pharmachem Limited has informed BSE Limited of a special window for the transfer and dematerialization (demat) of physical shares, pursuant to SEBI Circular No. HO/38/13/11/2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. The company published newspaper advertisements — one in English and one in a vernacular language — to notify shareholders of this facility. The communication was signed by Managing Director Bhawani Shankar Goyal on May 14, 2026.

Special Window: Key Details

The special window is designed for shareholders holding physical securities whose transfer deeds were executed and sold or purchased prior to April 01, 2019. The window remains open from February 05, 2026 to February 04, 2027. Only requests accompanied by original share certificates, transfer deeds, and relevant supporting documents will be considered under this facility.

The following eligibility matrix outlines the conditions under which shareholders may lodge their physical securities:

Lock-In and Transfer Restrictions

Securities transferred under this special window shall be mandatorily credited to the transferee in demat mode only. Such securities will be placed under a lock-in period of one year from the date of registration of transfer. During this lock-in period, the securities shall not be transferred, lien-marked, or pledged.

Registrar and Share Transfer Agent Contact

Shareholders with queries regarding this special window are requested to contact the company's Registrar and Share Transfer Agents:

The notice was issued by order of the Board of Omkar Pharmachem Ltd., signed by Managing Director Bhawani Shankar Goyal (DIN: 03255904), dated May 13, 2026, from Ahmedabad.